Type 1 Diabetes Mellitus
3 competing products in clinical development for Type 1 Diabetes Mellitus.
Pipeline by Phase
Pre-clinical1
Phase 11
Phase 2/31
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Teplizumab + Placebo | Eli Lilly | Phase 2/3 | Completed | 65 |
| teplizumab or placebo | Eli Lilly | Phase 1 | Terminated | 33 |
| Insulin Lispro | Eli Lilly | Pre-clinical | Completed | 23 |